38 results on '"Drapier N."'
Search Results
2. Variation in paediatric hospital antibiotic guidelines in Europe
- Author
-
Spyridis, N, Syridou, G, Goossens, H, Versporten, A, Kopsidas, J, Kourlaba, G, Bielicki, J, Drapier, N, Zaoutis, T, Tsolia, M, Sharland, M, Vergison, A, Léon, V, Delestrait, M, Huza, C, Lepage, P, Mahieu, L, Boy, T, Jansens, H, Van der Linden, D, Briquet, C, Allegaert, K, Smits, A, Gabriels, P, Vuye, A, Lutsar, I, Tamm, E, Larionova, A, Laan, D, Orbach, M, Lorrot, M, Angoulvant, F, Prot-Labarthe, S, Dubos, F, Lagree, M, Hufnagel, M, Schuster, K, Henneke, P, Roilides, E, Iosifidis, E, Corovessi, V, Michos, A, Galanakis, E, Gkentzi, D, Giacquinto, C, Longo, G, Dona, D, Mion, T, DʼArgenio, P, Degli, ML Ciofi, De Luca, M, Ciliento, G, Esposito, S, Danieli, E, Montinaro, V, Tenconi, R, Nicolini, G, Sviestina, C I Montagnani, Pavare, J, Rasnaca, K, Gardovska, D, Grope, I, Usonis, V, Gurksniene, V, Eidukaite, A, Biver, A, Brett, A, Esteves, I, Cambrea, SC, Craiu, M, Tomescu, E, Cizman, M, Babnik, J, Kenda, R, Vidmar, I, Nunez-Cuadros, E, Rojo, P, Lopez-Varela, E, Ureta, N, Mosqueda, R, Perez-Lopez, A, Orta, L, Santos, M, Navarro, M, Santiago, B, Hernandez-Sampelaya, T, Saavedra, J, Pineiro, R, Torel, P, Mate Cano, I, Baumann, P, Berger, C, Menson, E, Botgros, A, Doerholt, K, Drysdale, S, Makwana, N, McCorry, A, Garbash, EM, Chetcutiganado, C, McLeod, M, Caldwell, N, Nash, C, McCullagh, B, Sharpe, D, Tweddell, L, Liese, JG, Aston, J, Gallagher, A, Satodia, P, Howard-Smith, N, Korinteli, I, Tavchioska, G, Jensen, L, Trethon, A, Unuk, S, Childs, N, and Canlas, J
- Published
- 2016
- Full Text
- View/download PDF
3. The European Surveillance of Antimicrobial Consumption (ESAC) survey of wound prevalence and antibiotic use in 270 European nursing homes in 2009: O472
- Author
-
Broex, E., Latour, K., Muller, A., Drapier, N., Vankerckhoven, V., Stroobants, R., Goossens, H., and Jans, B.
- Published
- 2010
4. Impact of medical care and coordination on antibiotic policy and consumption: data of the European Surveillance of Antimicrobial Consumption (ESAC) nursing home subproject: O471
- Author
-
Latour, K., Broex, E., Muller, A., Drapier, N., Vankerckhoven, V., Stroobants, R., Goossens, H., and Jans, B.
- Published
- 2010
5. High Rates of Prescribing Antimicrobials for Prophylaxis in Children and Neonates: Results From the Antibiotic Resistance and Prescribing in European Children Point Prevalence Survey
- Author
-
Hufnagel, M, Versporten, A, Bielicki, J, Drapier, N, Sharland, M, Goossens, H, and ARPEC Project Group
- Abstract
Background: This study was conducted to assess the variation in prescription practices for systemic antimicrobial agents used for prophylaxis among pediatric patients hospitalized in 41 countries worldwide. Methods: Using the standardized Antibiotic Resistance and Prescribing in European Children Point Prevalence Survey protocol, a cross-sectional point-prevalence survey was conducted at 226 pediatric hospitals in 41 countries from October 1 to November 30, 2012. Results: Overall, 17693 pediatric patients were surveyed and 36.7% of them received antibiotics (n = 6499). Of 6818 inpatient children, 2242 (32.9%) received at least 1 antimicrobial for prophylactic use. Of 11899 prescriptions for antimicrobials, 3400 (28.6%) were provided for prophylactic use. Prophylaxis for medical diseases was the indication in 73.4% of cases (2495 of 3400), whereas 26.6% of prescriptions were for surgical diseases (905 of 3400). In approximately half the cases (48.7% [1656 of 3400]), a combination of 2 or more antimicrobials was prescribed. The use of broad-spectrum antibiotics (BSAs), which included tetracyclines, macrolides, lincosamides, and sulfonamides/trimethoprim, was high (51.8% [1761 of 3400]). Broad-spectrum antibiotic use for medical prophylaxis was more common in Asia (risk ratio [RR], 1.322; 95% confidence interval [CI], 1.202-1.653) and more restricted in Australia (RR, 0.619; 95% CI, 0.521-0.736). Prescription of BSA for surgical prophylaxis also varied according to United Nations region. Finally, a high percentage of surgical patients (79.7% [721 of 905]) received their prophylaxis for longer than 1 day. Conclusions: A high proportion of hospitalized children received prophylactic BSAs. This represents a clear target for quality improvement. Collectively speaking, it is critical to reduce total prophylactic prescribing, BSA use, and prolonged prescription.
- Published
- 2019
6. Variation in paediatric hospital antibiotic guidelines in Europe
- Author
-
Spyridis, N., Syridou, G., Goossens, H., Versporten, A., Kopsidas, J., Kourlaba, G., Bielicki, J., Drapier, N., Zaoutis, T., Tsolia, M., Sharland, M., Vergison, A., Leon, V., Delestrait, M., Huza, C., Lepage, P., Mahieu, L., Boy, T., Jansens, H., Van Der Linden, D., Briquet, C., Allegaert, K., Smits, A., Gabriels, P., Vuye, A., Lutsar, I., Tamm, E., Larionova, A., Laan, D., Orbach, M., Lorrot, M., Angoulvant, F., Prot-Labarthe, S., Dubos, F., Lagree, M., Hufnagel, M., Schuster, K., Henneke, P., Roilides, E., Iosifidis, E., Corovessi, V., Michos, A., Galanakis, E., Gkentzi, D., Giacquinto, C., Longo, G., Dona', D., Mion, T., D'Argenio, P., Degli, M. L. C., De Luca, M., Ciliento, G., Esposito, S., Danieli, E., Montinaro, V., Tenconi, R., Nicolini, G., Sviestina, C. I. M., Pavare, J., Rasnaca, K., Gardovska, D., Usonis, V., Grope, I., Gurksniene, V., Eidukaite, A., Biver, A., Brett, A., Esteves, I., Cambrea, S. C., Craiu, M., Tomescu, E., Cizman, M., Babnik, J., Kenda, R., Vidmar, I., Nunez-Cuadros, E., Rojo, P., Lopez-Varela, E., Ureta, N., Perez-Lopez, A., Mosqueda, R., Orta, L., Santos, M., Navarro, M., Santiago, B., Hernandez-Sampelaya, T., Saavedra, J., Pineiro, R., Torel, P., Cano, I. M., Baumann, P., Berger, C., Menson, E., Botgros, A., Doerholt, K., Drysdale, S., Makwana, N., Mccorry, A., Garbash, E. M., Chetcutiganado, C., Mcleod, M., Caldwell, N., Nash, C., Mccullagh, B., Sharpe, D., Tweddell, L., Liese, J. G., Aston, J., Gallagher, A., Satodia, P., Howard-Smith, N., Korinteli, I., Tavchioska, G., Jensen, L., Trethon, A., Unuk, S., Childs, N., Canlas, J., Mahieu, Ludo, and ARPEC Project Grp
- Subjects
Pediatrics ,practice guidelines as topic ,Antibiotics ,cross-sectional studies ,respiratory tract infections ,sepsis ,0302 clinical medicine ,newborn ,Medicine ,030212 general & internal medicine ,Practice Patterns, Physicians' ,humans ,European paediatric hospitals ,antibiotic guidelines ,childhood infection ,anti-bacterial agents ,bacterial infections ,child ,preschool ,drug administration schedule ,drug prescriptions ,Europe ,hospitals ,pediatric ,infant ,practice patterns ,physicians' ,urinary tract infections ,pediatrics ,perinatology and child health ,Antistaphylococcal penicillins ,Respiratory tract infections ,Neonatal sepsis ,Hospitals, Pediatric ,Child, Preschool ,medicine.drug ,medicine.medical_specialty ,medicine.drug_class ,Sepsis ,03 medical and health sciences ,030225 pediatrics ,Internal medicine ,business.industry ,Infant, Newborn ,Guideline ,Amoxicillin ,medicine.disease ,Penicillin ,Pediatrics, Perinatology and Child Health ,Human medicine ,business - Abstract
ObjectiveTo assess the availability and source of guidelines for common infections in European paediatric hospitals and determine their content and characteristics.DesignParticipating hospitals completed an online questionnaire on the availability and characteristics of antibiotic prescribing guidelines and on empirical antibiotic treatment including duration of therapy for 5 common infection syndromes: respiratory tract, urinary tract, skin and soft tissue, osteoarticular and sepsis in neonates and children.Results84 hospitals from 19 European countries participated in the survey of which 74 confirmed the existence of guidelines. Complete guidelines (existing guidelines for all requested infection syndromes) were reported by 20% of hospitals and the majority (71%) used a range of different sources. Guidelines most commonly available were those for urinary tract infection (UTI) (74%), neonatal sepsis (71%) and sepsis in children (65%). Penicillin and amoxicillin were the antibiotics most commonly recommended for respiratory tract infections (RTIs) (up to 76%), cephalosporin for UTI (up to 50%) and for skin and soft tissue infection (SSTI) and bone infection (20% and 30%, respectively). Antistaphylococcal penicillins were recommended for SSTIs and bone infections in 43% and 36%, respectively. Recommendations for neonatal sepsis included 20 different antibiotic combinations. Duration of therapy guidelines was mostly available for RTI and UTI (82%). A third of hospitals with guidelines for sepsis provided recommendations for length of therapy.ConclusionsComprehensive antibiotic guideline recommendations are generally lacking from European paediatric hospitals. We documented multiple antibiotics and combinations for most infections. Considerable improvement in the quality of guidelines and their evidence base is required, linking empirical therapy to resistance rates.
- Published
- 2015
- Full Text
- View/download PDF
7. An integrative eco-epidemiological analysis of West Nile virus transmission
- Author
-
Tran, Annelise, L'Ambert, G., Balança, G., Pradier, S., Grosbois, V., Balenghien, Thomas, Baldet, T., LECOLLINET, S., Leblond, Agnès, Gaidet-Drapier, N., Animal et gestion intégrée des risques (UPR AGIRs), Centre de Coopération Internationale en Recherche Agronomique pour le Développement (Cirad), Groupement d'Intérêt Public Cyclotron Réunion Océan Indien, Partenaires INRAE, Entente Interdépartementale pour la Démoustication du Littoral Méditerranéen, Ecole Nationale Vétérinaire de Toulouse (ENVT), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Animal, Santé, Territoires, Risques et Ecosystèmes (UMR ASTRE), Centre de Coopération Internationale en Recherche Agronomique pour le Développement (Cirad)-Institut National de la Recherche Agronomique (INRA), Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES), Unité Mixte de Recherche d'Épidémiologie des maladies Animales et zoonotiques (UMR EPIA), and Institut National de la Recherche Agronomique (INRA)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)
- Subjects
[SDV]Life Sciences [q-bio] ,viruses ,L73 - Maladies des animaux ,Hôte ,Système d'information géographique ,Dynamique des populations ,geographic information system ,arboviral transmission ,virus diseases ,Épidémiologie ,spatial epidemiology ,West Nile virus ,L72 - Organismes nuisibles des animaux ,Modèle mathématique ,Gestion du risque ,camargue ,Sérologie ,modelling ,disease ecology ,Transmission des maladies ,Flavivirus ,Migration animale ,Distribution spatiale ,Modèle de simulation ,Oiseau ,Animal sauvage ,nervous system diseases ,Culicidae ,Southern France ,Écologie animale ,Cheval - Abstract
International audience; West Nile disease, caused by the West Nile virus (WNV), is a mosquito-borne zoonotic disease affecting humans and horses that involves wild birds as amplifying hosts. The mechanisms of WNV transmission remain unclear in Europe where the occurrence of outbreaks has dramatically increased in recent years. We used a dataset on the competence, distribution, abundance, diversity and dispersal of wild bird hosts and mosquito vectors to test alternative hypotheses concerning the transmission of WNV in Southern France. We modelled the successive processes of introduction, amplification, dispersal and spillover of WNV to incidental hosts based on host-vector contact rates on various land cover types and over four seasons. We evaluated the relative importance of the mechanisms tested using two independent serological datasets of WNV antibodies collected in wild birds and horses. We found that the same transmission processes (seasonal virus introduction by migratory birds, Culex modestus mosquitoes as amplifying vectors, heterogeneity in avian host competence, absence of 'dilution effect') best explain the spatial variations in WNV seroprevalence in the two serological datasets. Our results provide new insights on the pathways of WNV introduction, amplification and spillover and the contribution of bird and mosquito species to WNV transmission in Southern France.
- Published
- 2017
- Full Text
- View/download PDF
8. Gestion, Naturalité et Biodiversité : présentation générale du projet de recherche et de son approche
- Author
-
Frédéric Gosselin, Yoan Paillet, Marion Gosselin, Durrieu, S., Laurent Larrieu, Anders Mårell, Boulanger, V., Debaive, N., Frédéric Archaux, Bouget, C., Gilg, O., Roquencourt, A., Drapier, N., Dauffy Richard, E., Ecosystèmes forestiers (UR EFNO), Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA), Territoires, Environnement, Télédétection et Information Spatiale (UMR TETIS), Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)-Centre de Coopération Internationale en Recherche Agronomique pour le Développement (Cirad)-AgroParisTech-Centre National de la Recherche Scientifique (CNRS), Dynamiques Forestières dans l'Espace Rural (DYNAFOR), Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Ecole Nationale Supérieure Agronomique de Toulouse, Réserves Naturelles de France, Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)-AgroParisTech-Centre National de la Recherche Scientifique (CNRS)-Centre de Coopération Internationale en Recherche Agronomique pour le Développement (Cirad), Dynamiques et écologie des paysages agriforestiers (DYNAFOR), École nationale supérieure agronomique de Toulouse [ENSAT]-Institut National Polytechnique (Toulouse) (Toulouse INP), and Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)
- Subjects
GESTION FORESTIERE ,FORET ,forest exploitation ,MODELE STATISTIQUE ,INDICATEUR DE BIODIVERSITE ,PEUPLEMENT FORESTIER ,RECHERCHE ,RESERVE BIOLOGIQUE ,RESERVE NATURELLE ,biological reserve ,biodiversity indicator ,biodiversity ,ANALYSE STATISTIQUE ,forests ,research ,BIODIVERSITE ,statistical model ,methodology ,STRATEGIE D'ECHANTILLONNAGE ,EXPLOITATION FORESTIERE ,nature reserves ,sampling strategy ,INVENTAIRE ,NATURALITE ,inventory ,forest stands ,[SDE]Environmental Sciences ,statistical methods ,naturalness ,METHODOLOGIE - Abstract
Pour saisir la portée et l'intérêt du projet GNB, il ne suffit pas de connaître ses objectifs, dûment fondés sur un bilan circonstancié de l'état des connaissances. Il faut aussi appréhender sa démarche « expérimentale », à commencer par la stratégie d'échantillonnage et d'inventaires ; il faut comprendre le choix de méthodes d'analyse statistique innovantes mais complexes, avec en particulier la notion de magnitude des effets pour que les résultats puissent avoir une « lecture » opérationnelle. Impossible de résumer en quelques mots la réflexion exigeante qui a présidé à la conception du projet.
- Published
- 2017
9. The need to observe Nature rigorously to imitate it in forest management
- Author
-
Boulanger, V., Drapier, N., Debaive, N., Gilg, O., Gosselin, Frédéric, Réserves Naturelles de France, Ecosystèmes forestiers (UR EFNO), and Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)
- Subjects
GESTION FORESTIERE ,FORET ,forest exploitation ,ACTION ANTHROPIQUE ,DYNAMIQUE DU PEUPLEMENT ,PATRIMOINE NATUREL ,stand dynamics ,ACTIVITE HUMAINE ,PEUPLEMENT FORESTIER ,ECOLOGIE FORESTIERE ,RESERVE BIOLOGIQUE ,anthropic activity ,nature protection ,forest ecology ,RESERVE NATURELLE ,biological reserve ,biodiversity ,forests ,BIODIVERSITE ,EXPLOITATION FORESTIERE ,nature reserves ,PROTECTION DE LA NATURE ,NATURALITE ,forest stands ,natural heritage ,[SDE]Environmental Sciences ,naturalness - Abstract
Le réseau des réserves forestières a plus de 150 ans. Il s'est beaucoup étoffé durant les dernières décennies. Outil de conservation de la Nature, il permet aussi d'inspirer la gestion courante. Pour cela une observation rigoureuse de la biodiversité et des peuplements est nécessaire. C'est ce que propose le projet GNB.
- Published
- 2017
10. The worldwide antibiotic resistance and prescribing in european children (ARPEC) point prevalence survey: Developing hospital-quality indicators of antibiotic prescribing for children
- Author
-
Versporten, A. Bielicki, J. Drapier, N. Sharland, M. Goossens, H. Calle, G.M. Clark, J. Cooper, C. Blyth, C.C. Francis, J.R. Alsalman, J. Jansens, H. Mahieu, L. Van Rossom, P. Vandewal, W. Lepage, P. Blumental, S. Briquet, C. Robbrecht, D. Maton, P. Gabriels, P. Rubic, Z. Kovacevic, T. Nielsen, J.P. Petersen, J.R. Poorisrisak, P. Jensen, L.H. Laan, M. Tamm, E. Matsinen, M. Rummukainen, M.-L. Gajdos, V. Olivier, R. Le Maréchal, F. Martinot, A. Prot-Labarthe, S. Lorrot, M. Orbach, D. Pagava, K. Hufnagel, M. Knuf, M. Schlag, S.A.A. Liese, J. Renner, L. Enimil, A. Awunyo, M. Syridou, G. Spyridis, N. Critselis, E. Kouni, S. Mougkou, K. Ladomenou, F. Gkentzi, D. Iosifidis, E. Roilides, E. Sahu, S. Murki, S. Malviya, M. Kalavalapalli, D.B. Singh, S. Singhal, T. Garg, G. Garg, P. Kler, N. Soltani, J. Jafarpour, Z. Pouladfar, G. Nicolini, G. Montagnani, C. Galli, L. Esposito, S. Vecchio, A.L. Dona', D. Giaquinto, C. Borgia, E. D'Argenio, P. De Luca, M. Centenari, C. Raka, L. Omar, A. Al-Mousa, H. Mozgis, D. Sviestina, I. Burokiene, S. Usonis, V. Tavchioska, G. Hargadon-Lowe, A. Zarb, P. Borg, M.A. González Lozano, C.A. Castañon, P.Z. Cancino, M.E. McCullagh, B. McCorry, A. Gormley, C. Al Maskari, Z. Al-Jardani, A. Pluta, M. Rodrigues, F. Brett, A. Esteves, I. Marques, L. AlAjmi, J.A. Cambrea, S.C. Rashed, A.N. Al Azmi, A.A.M. Chan, S.M. Isa, M.S. Najdenov, P. Čižman, M. Unuk, S. Finlayson, H. Dramowski, A. Maté-Cano, I. Soto, B. Calvo, C. Santiago, B. Saavedra-Lozano, J. Bustinza, A. Escosa-García, L. Ureta, N. Tagarro, A. Barrero, P.T. Rincon-Lopez, E.M. Abubakar, I. Aston, J. Heginbothom, M. Satodia, P. Garbash, M. Johnson, A. Sharpe, D. Barton, C. Menson, E. Arenas-Lopez, S. Luck, S. Doerholt, K. McMaster, P. Caldwell, N.A. Lunn, A. Drysdale, S.B. Howe, R. Scorrer, T. Gahleitner, F. Gupta, R. Nash, C. Alexander, J. Raman, M. Bell, E. Rajagopal, V. Kohlhoff, S. Cox, E. Zaoutis, T. ARPEC project group
- Abstract
Objectives: Previously, web-based tools for cross-sectional antimicrobial point prevalence surveys (PPSs) have been used in adults to develop indicators of quality improvement. We aimed to determine the feasibility of developing similar quality indicators of improved antimicrobial prescribing focusing specifically on hospitalized neonates and children worldwide. Methods: A standardized antimicrobial PPS method was employed. Included were all inpatient children and neonates receiving an antimicrobial at 8:00 am on the day of the PPS. Denominators included the total number of inpatients. A web-based application was used for data entry, validation and reporting. We analysed 2012 data from 226 hospitals (H) in 41 countries (C) from Europe (174H; 24C), Africa (6H; 4C), Asia (25H; 8C), Australia (6H), Latin America (11H; 3C) and North America (4H). Results: Of 17 693 admissions, 6499 (36.7%) inpatients received at least one antimicrobial, but this varied considerably between wards and regions. Potential indicators included very high broad-spectrum antibiotic prescribing in children of mainly ceftriaxone (ranked first in Eastern Europe, 31.3%; Asia, 13.0%; Southern Europe, 9.8%), cefepime (ranked third in North America, 7.8%) and meropenem (ranked first in Latin America, 13.1%). The survey identified worryingly high use of critically important antibiotics for hospital-acquired infections in neonates (34.9%; range from 14.2% in Africa to 68.0% in Latin America) compared with children (28.3%; range from 14.5% in Africa to 48.9% in Latin America). Parenteral administration was very common among children in Asia (88%), Latin America (81%) and Europe (67%). Documentation of the reasons for antibiotic prescribing was lowest in Latin America (52%). Prolonged surgical prophylaxis rates ranged from 78% (Europe) to 84% (Latin America). Conclusions: Simple web-based PPS tools provide a feasible method to identify areas for improvement of antibiotic use, to set benchmarks and to monitor future interventions in hospitalized neonates and children. To our knowledge, this study has derived the first global quality indicators for antibiotic use in hospitalized neonates and children. © The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.
- Published
- 2016
11. Variation in paediatric hospital antibiotic guidelines in Europe
- Author
-
Spyridis, N. Syridou, G. Goossens, H. Versporten, A. Kopsidas, J. Kourlaba, G. Bielicki, J. Drapier, N. Zaoutis, T. Tsolia, M. Sharland, M. Vergison, A. Léon, V. Delestrait, M. Huza, C. Lepage, P. Mahieu, L. Boy, T. Jansens, H. Van Der Linden, D. Briquet, C. Allegaert, K. Smits, A. Gabriels, P. Vuye, A. Lutsar, I. Tamm, E. Larionova, A. Laan, D. Orbach, M. Lorrot, M. Angoulvant, F. Prot-Labarthe, S. Dubos, F. Lagree, M. Hufnagel, M. Schuster, K. Henneke, P. Roilides, E. Iosifidis, E. Corovessi, V. Michos, A. Galanakis, E. Gkentzi, D. Giacquinto, C. Longo, G. Dona, D. Mion, T. D'Argenio, P. Degli, M.L.C. De Luca, M. Ciliento, G. Esposito, S. Danieli, E. Montinaro, V. Tenconi, R. Nicolini, G. Sviestina, C.I.M. Pavare, J. Rasnaca, K. Gardovska, D. Usonis, V. Grope, I. Gurksniene, V. Eidukaite, A. Biver, A. Brett, A. Esteves, I. Cambrea, S.C. Craiu, M. Tomescu, E. Cizman, M. Babnik, J. Kenda, R. Vidmar, I. Nunez-Cuadros, E. Rojo, P. Lopez-Varela, E. Ureta, N. Perez-Lopez, A. Mosqueda, R. Orta, L. Santos, M. Navarro, M. Santiago, B. Hernandez-Sampelaya, T. Saavedra, J. Pineiro, R. Torel, P. Cano, I.M. Baumann, P. Berger, C. Menson, E. Botgros, A. Doerholt, K. Drysdale, S. Makwana, N. McCorry, A. Garbash, E.M. Chetcutiganado, C. McLeod, M. Caldwell, N. Nash, C. McCullagh, B. Sharpe, D. Tweddell, L. Liese, J.G. Aston, J. Gallagher, A. Satodia, P. Howard-Smith, N. Korinteli, I. Tavchioska, G. Jensen, L. Trethon, A. Unuk, S. Childs, N. Canlas, J.
- Abstract
Objective: To assess the availability and source of guidelines for common infections in European paediatric hospitals and determine their content and characteristics. Design: Participating hospitals completed an online questionnaire on the availability and characteristics of antibiotic prescribing guidelines and on empirical antibiotic treatment including duration of therapy for 5 common infection syndromes: respiratory tract, urinary tract, skin and soft tissue, osteoarticular and sepsis in neonates and children. Results: 84 hospitals from 19 European countries participated in the survey of which 74 confirmed the existence of guidelines. Complete guidelines (existing guidelines for all requested infection syndromes) were reported by 20% of hospitals and the majority (71%) used a range of different sources. Guidelines most commonly available were those for urinary tract infection (UTI) (74%), neonatal sepsis (71%) and sepsis in children (65%). Penicillin and amoxicillin were the antibiotics most commonly recommended for respiratory tract infections (RTIs) (up to 76%), cephalosporin for UTI (up to 50%) and for skin and soft tissue infection (SSTI) and bone infection (20% and 30%, respectively). Antistaphylococcal penicillins were recommended for SSTIs and bone infections in 43% and 36%, respectively. Recommendations for neonatal sepsis included 20 different antibiotic combinations. Duration of therapy guidelines was mostly available for RTI and UTI (82%). A third of hospitals with guidelines for sepsis provided recommendations for length of therapy. Conclusions: Comprehensive antibiotic guideline recommendations are generally lacking from European paediatric hospitals. We documented multiple antibiotics and combinations for most infections. Considerable improvement in the quality of guidelines and their evidence base is required, linking empirical therapy to resistance rates.
- Published
- 2016
12. The worldwide antibiotic resistance and prescribing in european children (ARPEC) point prevalence survey: Developing hospital-quality indicators of antibiotic prescribing for children.
- Author
-
Soltani J., Kovacevic T., Nielsen J.P., Petersen J.R., Poorisrisak P., Jensen L.H., Laan M., Tamm E., Matsinen M., Rummukainen M.-L., Gajdos V., Olivier R., Le Marechal F., Martinot A., Prot-Labarthe S., Lorrot M., Orbach D., Pagava K., Hufnagel M., Knuf M., Schlag S.A.A., Liese J., Renner L., Enimil A., Awunyo M., Syridou G., Spyridis N., Critselis E., Kouni S., Mougkou K., Ladomenou F., Gkentzi D., Iosifidis E., Roilides E., Sahu S., Murki S., Malviya M., Kalavalapalli D.B., Singh S., Singhal T., Garg G., Garg P., Kler N., Jafarpour Z., Pouladfar G., Nicolini G., Montagnani C., Galli L., Esposito S., Vecchio A.L., Dona' D., Giaquinto C., Borgia E., D'Argenio P., De Luca M., Centenari C., Raka L., Omar A., Al-Mousa H., Mozgis D., Sviestina I., Burokiene S., Usonis V., Tavchioska G., Hargadon-Lowe A., Zarb P., Borg M.A., Gonzalez Lozano C.A., Castanon P.Z., Cancino M.E., McCullagh B., McCorry A., Gormley C., Al Maskari Z., Al-Jardani A., Pluta M., Rodrigues F., Brett A., Esteves I., Marques L., AlAjmi J.A., Cambrea S.C., Rashed A.N., Al Azmi A.A.M., Chan S.M., Isa M.S., Najdenov P., Cizman M., Unuk S., Finlayson H., Dramowski A., Mate-Cano I., Soto B., Calvo C., Santiago B., Saavedra-Lozano J., Bustinza A., Escosa-Garcia L., Ureta N., Tagarro A., Barrero P.T., Rincon-Lopez E.M., Abubakar I., Aston J., Heginbothom M., Satodia P., Garbash M., Johnson A., Sharpe D., Barton C., Menson E., Arenas-Lopez S., Luck S., Doerholt K., McMaster P., Caldwell N.A., Lunn A., Drysdale S.B., Howe R., Scorrer T., Gahleitner F., Gupta R., Nash C., Alexander J., Raman M., Bell E., Rajagopal V., Kohlhoff S., Cox E., Zaoutis T., Versporten A., Bielicki J., Drapier N., Sharland M., Goossens H., Calle G.M., Clark J., Cooper C., Blyth C.C., Francis J.R., Alsalman J., Jansens H., Mahieu L., Van Rossom P., Vandewal W., Lepage P., Blumental S., Briquet C., Robbrecht D., Maton P., Gabriels P., Rubic Z., Soltani J., Kovacevic T., Nielsen J.P., Petersen J.R., Poorisrisak P., Jensen L.H., Laan M., Tamm E., Matsinen M., Rummukainen M.-L., Gajdos V., Olivier R., Le Marechal F., Martinot A., Prot-Labarthe S., Lorrot M., Orbach D., Pagava K., Hufnagel M., Knuf M., Schlag S.A.A., Liese J., Renner L., Enimil A., Awunyo M., Syridou G., Spyridis N., Critselis E., Kouni S., Mougkou K., Ladomenou F., Gkentzi D., Iosifidis E., Roilides E., Sahu S., Murki S., Malviya M., Kalavalapalli D.B., Singh S., Singhal T., Garg G., Garg P., Kler N., Jafarpour Z., Pouladfar G., Nicolini G., Montagnani C., Galli L., Esposito S., Vecchio A.L., Dona' D., Giaquinto C., Borgia E., D'Argenio P., De Luca M., Centenari C., Raka L., Omar A., Al-Mousa H., Mozgis D., Sviestina I., Burokiene S., Usonis V., Tavchioska G., Hargadon-Lowe A., Zarb P., Borg M.A., Gonzalez Lozano C.A., Castanon P.Z., Cancino M.E., McCullagh B., McCorry A., Gormley C., Al Maskari Z., Al-Jardani A., Pluta M., Rodrigues F., Brett A., Esteves I., Marques L., AlAjmi J.A., Cambrea S.C., Rashed A.N., Al Azmi A.A.M., Chan S.M., Isa M.S., Najdenov P., Cizman M., Unuk S., Finlayson H., Dramowski A., Mate-Cano I., Soto B., Calvo C., Santiago B., Saavedra-Lozano J., Bustinza A., Escosa-Garcia L., Ureta N., Tagarro A., Barrero P.T., Rincon-Lopez E.M., Abubakar I., Aston J., Heginbothom M., Satodia P., Garbash M., Johnson A., Sharpe D., Barton C., Menson E., Arenas-Lopez S., Luck S., Doerholt K., McMaster P., Caldwell N.A., Lunn A., Drysdale S.B., Howe R., Scorrer T., Gahleitner F., Gupta R., Nash C., Alexander J., Raman M., Bell E., Rajagopal V., Kohlhoff S., Cox E., Zaoutis T., Versporten A., Bielicki J., Drapier N., Sharland M., Goossens H., Calle G.M., Clark J., Cooper C., Blyth C.C., Francis J.R., Alsalman J., Jansens H., Mahieu L., Van Rossom P., Vandewal W., Lepage P., Blumental S., Briquet C., Robbrecht D., Maton P., Gabriels P., and Rubic Z.
- Abstract
Objectives: Previously, web-based tools for cross-sectional antimicrobial point prevalence surveys (PPSs) have been used in adults to develop indicators of quality improvement. We aimed to determine the feasibility of developing similar quality indicators of improved antimicrobial prescribing focusing specifically on hospitalized neonates and children worldwide. Method(s): A standardized antimicrobial PPS method was employed. Included were all inpatient children and neonates receiving an antimicrobial at 8:00 am on the day of the PPS. Denominators included the total number of inpatients. A web-based application was used for data entry, validation and reporting. We analysed 2012 data from 226 hospitals (H) in 41 countries (C) from Europe (174H; 24C), Africa (6H; 4C), Asia (25H; 8C), Australia (6H), Latin America (11H; 3C) and North America (4H). Result(s): Of 17 693 admissions, 6499 (36.7%) inpatients received at least one antimicrobial, but this varied considerably between wards and regions. Potential indicators included very high broad-spectrum antibiotic prescribing in children of mainly ceftriaxone (ranked first in Eastern Europe, 31.3%; Asia, 13.0%; Southern Europe, 9.8%), cefepime (ranked third in North America, 7.8%) and meropenem (ranked first in Latin America, 13.1%). The survey identified worryingly high use of critically important antibiotics for hospital-acquired infections in neonates (34.9%; range from 14.2% in Africa to 68.0% in Latin America) compared with children (28.3%; range from 14.5% in Africa to 48.9% in Latin America). Parenteral administration was very common among children in Asia (88%), Latin America (81%) and Europe (67%). Documentation of the reasons for antibiotic prescribing was lowest in Latin America (52%). Prolonged surgical prophylaxis rates ranged from 78% (Europe) to 84% (Latin America). Conclusion(s): Simple web-based PPS tools provide a feasible method to identify areas for improvement of antibiotic use, to set benchmarks and to
- Published
- 2016
13. Variation in paediatric hospital antibiotic guidelines in Europe.
- Author
-
UCL - SSS/IREC/PEDI - Pôle de Pédiatrie, UCL - (SLuc) Service de pédiatrie générale, UCL - (SLuc) Département de pharmacie, Spyridis, N, Syridou, G, Goossens, H, Versporten, A, Kopsidas, J, Kourlaba, G, Bielicki, J, Drapier, N, Zaoutis, T, Tsolia, M, Sharland, M, ARPEC Project Group Members, Van der Linden, Dimitri, Briquet, Caroline, UCL - SSS/IREC/PEDI - Pôle de Pédiatrie, UCL - (SLuc) Service de pédiatrie générale, UCL - (SLuc) Département de pharmacie, Spyridis, N, Syridou, G, Goossens, H, Versporten, A, Kopsidas, J, Kourlaba, G, Bielicki, J, Drapier, N, Zaoutis, T, Tsolia, M, Sharland, M, ARPEC Project Group Members, Van der Linden, Dimitri, and Briquet, Caroline
- Abstract
OBJECTIVE: To assess the availability and source of guidelines for common infections in European paediatric hospitals and determine their content and characteristics. DESIGN: Participating hospitals completed an online questionnaire on the availability and characteristics of antibiotic prescribing guidelines and on empirical antibiotic treatment including duration of therapy for 5 common infection syndromes: respiratory tract, urinary tract, skin and soft tissue, osteoarticular and sepsis in neonates and children. RESULTS: 84 hospitals from 19 European countries participated in the survey of which 74 confirmed the existence of guidelines. Complete guidelines (existing guidelines for all requested infection syndromes) were reported by 20% of hospitals and the majority (71%) used a range of different sources. Guidelines most commonly available were those for urinary tract infection (UTI) (74%), neonatal sepsis (71%) and sepsis in children (65%). Penicillin and amoxicillin were the antibiotics most commonly recommended for respiratory tract infections (RTIs) (up to 76%), cephalosporin for UTI (up to 50%) and for skin and soft tissue infection (SSTI) and bone infection (20% and 30%, respectively). Antistaphylococcal penicillins were recommended for SSTIs and bone infections in 43% and 36%, respectively. Recommendations for neonatal sepsis included 20 different antibiotic combinations. Duration of therapy guidelines was mostly available for RTI and UTI (82%). A third of hospitals with guidelines for sepsis provided recommendations for length of therapy. CONCLUSIONS: Comprehensive antibiotic guideline recommendations are generally lacking from European paediatric hospitals. We documented multiple antibiotics and combinations for most infections. Considerable improvement in the quality of guidelines and their evidence base is required, linking empirical therapy to resistance rates.
- Published
- 2016
14. Gestion forestière, naturalité et biodiversité
- Author
-
Frédéric Gosselin, Yoan Paillet, Marion Gosselin, Durrieu, S., Laurent Larrieu, Anders Mårell, Lucie, X., Boulanger, V., Debaive, N., Frédéric Archaux, Christophe Bouget, Olivier Gilg, Rocquencourt, A., Drapier, N., Dauffy Richard, E., Ecosystèmes forestiers (UR EFNO), Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA), Territoires, Environnement, Télédétection et Information Spatiale (UMR TETIS), Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)-AgroParisTech-Centre de Coopération Internationale en Recherche Agronomique pour le Développement (Cirad), Institut National de la Recherche Agronomique (INRA), Office National des Forêts (ONF), RESERVES NATURELLES DE FRANCE QUETIGNY FRA, Partenaires IRSTEA, Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)-Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA), National hors Recherche (appel d'offres national ou régional), irstea, MEDDE, contrat MEDDE/MAAF : 10-MBGD-BGF-1-CVS-092, n°CHORUS 2100 214 651, and Irstea Publications, Migration
- Subjects
[SDE] Environmental Sciences ,DEGRE DE NATURALITE ,[SDE]Environmental Sciences ,MESURE DE LA BIODIVERSITE ,MODELES STATISTIQUES BAYESIENS ,BIODIVERSITE FORESTIERE - Abstract
Extending the network of strict forest reserves is one of the conservation measures promoted by the French National Strategy for Biodiversity improvement. According to the scientific literature, strict forest reserves may help preserving a part of the biodiversity that is threatened by forest management. However, this management choice is based on poor knowledge in the French context and the studies concerned may suffer from methodological shortcomings. The national-scale project named “Forest management, Naturalness and Biodiversity” aims at quantifying the effects on forest structure and biodiversity of management abandonment in the strict reserves. Based on a worldwide meta-analysis and 213 study plots set up in 15 forest sites throughout France, we analysed the response of 7 taxonomic groups to management abandonment. On the one hand, we show that forest management affects total richness of saproxylic taxa worldwide, in particular bryophytes and saproxylic fungi. On the other hand, this trend is verified on our dataset. However, management abandonment per se is not always the best explanation of the differences between managed and unmanaged forests, but other variables, notably linked to deadwood, better explain the observed patterns for these groups. For the other taxa, the response is weakest but depends more on structural features than on management abandonment. In terms of policy, our project has allowed methodological advances thanks to the development of inventory and remote sensing protocols, as well as statistical methods. The dataset we have gathered is also a first comparison of structure and biodiversity between strict forest reserves and managed forest for France. This network may therefore constitute a first basis for long term biodiversity monitoring in French forests., L'extension raisonnée du réseau de réserves forestières intégrales fait partie des mesures adoptées par la Stratégie Nationale pour la Biodiversité pour améliorer la biodiversité forestière métropolitaine française. Au regard de la littérature scientifique, la non-exploitation favoriserait une partie de la biodiversité forestière menacée par la gestion forestière traditionnelle, mais les connaissances qui sous-tendent ce choix se révèlent très partielles et souffrent de problèmes méthodologiques. D’envergure nationale, le projet « Gestion forestière, Naturalité et Biodiversité » (GNB ; http://gnb.irstea.fr) a pour objectif principal d’étudier l’impact de l’arrêt d’exploitation forestière dans le réseau des réserves forestières intégrales sur la structure des peuplements et sur la biodiversité Sur la base d’une méta-analyse et de 213 placettes installées dans 15 massifs forestiers français, nous avons analysé la réponse de 7 groupes taxonomiques à l’arrêt d’exploitation. Nous montrons d’une part que les résultats mondiaux confirment que l’exploitation affecte la richesse des taxons saproxyliques, notamment bryophytes et champignons, et que, d’autre part, cette tendance se vérifie pour le jeu de données issu du projet. Cependant, la mise en réserve en tant que telle n’est la plupart du temps pas la meilleure explication des différences entre peuplements exploités et non exploités, mais d’autres variables, liées au bois mort notamment, expliquent mieux les patrons pour ces groupes. Pour les autres taxons, la réponse est plus faible mais dépend plus de la structure du peuplement que de la mise en réserve. En termes d’appui aux politiques publiques, le projet a permis des avancées méthodologiques notamment grâce au développement de protocoles d’inventaires et de télédétection, et de méthodes statistiques. Le jeu de données acquis constitue par ailleurs un premier état des lieux de la structure forestière et de la biodiversité des réserves forestières intégrales en France, en comparaison avec des forêts exploitées. Ce dispositif pourrait ainsi servir de première base à un suivi au long cours de la biodiversité des forêts françaises.
- Published
- 2014
15. Quelles quantités de bois mort dans les réserves forestières françaises ? Bilan de 8 années d’inventaire
- Author
-
Debaive, N., Boulanger, V., Drapier, N., Duchamp, L., Paillet, Yoan, Gosselin, Frédéric, Bruciamacchie, M., Gilg, Olivier, RESERVES NATURELLES DE FRANCE QUETIGNY FRA, Partenaires IRSTEA, Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)-Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA), Office National des Forêts (ONF), Ecosystèmes forestiers (UR EFNO), Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA), and AgroParisTech
- Subjects
RESERVE FORESTIERE ,SUIVI ,[SDE]Environmental Sciences - Abstract
National audience; Le réseau des réserves forestières (naturelles et biologiques) constitue un formidable support d’étude de la dynamique et de la biodiversité forestière. Néanmoins, et jusque récemment, seuls quelques sites avaient fait l’objet d’une évaluation précise du bois mort, dont l’importance pour la survie de nombreuses espèces forestières n’est plus à démontrer. Dans ce contexte et à la demande des gestionnaires, un protocole de suivi dendrométrique destiné aux réserves forestières (PSDRF) a été élaboré en 2005, sous la conduite de l’ENGREF. Par le biais de placettes permanentes, sa mise en oe½uvre permet non seulement de décrire les peuplements forestiers échantillonnés mais aussi d’approfondir les connaissances sur la dynamique de ces peuplements dans le temps et l’espace. Coordonné depuis 2008 dans le cadre d’un partenariat entre l’ONF et RNF, ce protocole a, à ce jour, été appliqué sur plus de 80 réserves, soit plus de 7000 placettes relevées sur près de 40 000 ha et couvrant ainsi la majorité des grands types d'habitats forestiers français. En moyenne, on observe que les réserves contiennent un volume de bois mort non négligeable (moyenne : 37,1 m3/ha, variant de 5 à 150 m3/ha). A quelques exceptions près, les réserves intégrales contiennent plus de bois mort que les réserves qui font l’objet d’une exploitation.
- Published
- 2013
16. Structure and biodiversity in managed and unmanaged mixed beech forests: a comparison based on the strict forest reserves network in France
- Author
-
Paillet, Yoan, Pernot, C., Boulanger, V., Debaive, N., Drapier, N., Gilg, Olivier, Hirbec, P., Gosselin, Frédéric, Ecosystèmes forestiers (UR EFNO), Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA), Office National des Forêts (ONF), RESERVES NATURELLES DE FRANCE QUETIGNY FRA, Partenaires IRSTEA, Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)-Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA), and Irstea Publications, Migration
- Subjects
[SDE] Environmental Sciences ,STRUCTURE ,[SDE]Environmental Sciences ,FRANCE ,BIODIVERSITY ,STRICT FOREST RESERVE ,FOREST MANAGEMENT ,MULTITAXA - Abstract
International audience; In Western Europe, the long history of forest management over the past centuries has shaped both landscape and local scale forest structure, presumably altering the biodiversity of forest dwelling species. In France, the strict forest reserves network has been created to serve as a witness to gauge the effects of management on forest structures and dynamics: it currently covers 0.3% of national territory, distributed over 200 sites representative of the main forest types. However, to date, research comparing biodiversity in managed and unmanaged forests remains strikingly poor in Western Europe, and hardly proposes a broad taxonomic assessment. In order to fill the gap in knowledge in the French context, we studied forest structure and biodiversity in lowland oak-beech-hornbeam forests, and in montane beech-fir-spruce forests. We compared living and dead wood amounts and biodiversity of 6 taxa (vascular plants, saproxylic fungi, birds, bats, carabids and saproxylic beetles) 15 strict forest reserves where forest management has been abandoned for at least 20 years and adjacent managed forests, totalizing 213 plots. Relatively to managed forest, stands in unmanaged forest host larger amounts of old-growth components (deadwood volumes, number of large trees) as well as higher basal areas, whereas other stand characteristics did not differ significantly. Saproxylic fungi responded significantly to management abandonment, their total richness increasing with time since last harvesting. Responses of the other taxonomic groups were less clear and further analyses correlating forest structure with taxa or ecological groups are necessary to better understand the mechanisms associating biodiversity and forest management. The applied outcome of this multitaxonomic approach is to validate indirect biodiversity indicators on a broad gradient of forest management. This project constitutes the first reference for mixed beech forests in France and may help managers to define thresholds in terms of biodiversity oriented measures.
- Published
- 2013
17. Première évaluation à grande échelle du volume de bois mort dans les réserves forestières françaises, liens avec la biodiversité, conséquences pour la gestion
- Author
-
Debaive, N., Paillet, Yoan, Pernot, C., Boulanger, V., Hirbec, P., Drapier, N., Duchamp, L., Gosselin, Frédéric, Bruciamacchie, M., Gilg, Olivier, RESERVES NATURELLES DE FRANCE QUETIGNY FRA, Partenaires IRSTEA, Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)-Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA), Ecosystèmes forestiers (UR EFNO), Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA), Office National des Forêts (ONF), and AgroParisTech
- Subjects
[SDE]Environmental Sciences ,RESERVE INTEGRALE - Abstract
National audience; Au carrefour entre différentes régions biogéographiques, la France héberge une grande diversité d'habitats et de peuplements forestiers. Cette diversité résulte non seulement de la combinaison de facteurs géographiques, géologiques et climatiques, mais également de siècles d’exploitation qui ont façonné le paysage forestier. Supports de la présente étude, les réserves biologiques (gérées par l’ONF) et les réserves naturelles (regroupées au sein de RNF), à forte composante forestière, sont représentatives de cette diversité des forêts françaises. Elles présentent également un gradient de gestion important, allant de l’exploitation mécanique à la libre évolution. Jusqu'à récemment, les estimations du volume de bois morts dans les forêts françaises étaient extrêmement imprécises. En cause : (1°) une prise en compte inadaptée dans les méthodes courantes d'inventaires, tournées vers le suivi de la ressource et (2°) un très faible nombre de sites étudiés de façon précise (e.g. Fontainebleau, Massane). Dans ce contexte, à la demande des gestionnaires et sous l'égide du ministère de l'Ecologie, le protocole de suivi dendrométrique des réserves forestières (PSDRF) a été élaboré en 2005. Coordonné depuis 2008 dans le cadre d’un partenariat entre l’ONF et RNF, ce protocole a, à ce jour, été appliqué sur plus de 80 réserves, représentant près de 7000 placettes et couvrant ainsi la majorité des grands types d'habitats forestiers français. Par le biais de placettes permanentes, sa mise en oeuvre permet non seulement de décrire les peuplements forestiers échantillonnés (et donc de participer à l’évaluation de l'état de conservation des habitats) mais aussi, et c’est la principale originalité de ce protocole, d’approfondir les connaissances sur la dynamique de ces peuplements dans le temps et l’espace (accroissement naturel, vitesse de décomposition, flux de nécromasse, etc.). Basés sur des données dendrométriques collectées dans quelques 60 réserves, les premiers résultats montrent que la plupart des réserves forestières contiennent un volume de bois mort nonnégligeable (moyenne : 37,1 m3/ha, fourchette allant de 5 à 150 m3/ha). A quelques exceptions près, les réserves intégrales (soustraites à toute exploitation) contiennent plus de bois mort que les réserves qui font l’objet d’une exploitation. Comparé aux résultats préliminaires du dernier inventaire IGN (2008-2010), les réserves forestières se trouvent à des niveaux de bois mort globalement plus élevés que pour la forêt française dans son ensemble (23,1 m3/ha). C’est particulièrement le cas pour les arbres morts sur pied mais certaines différences qualitatives sont également identifiées pour le bois mort au sol. Par ailleurs, dans sa phase initiale de description, des inventaires taxonomiques peuvent venir se superposer au PSDRF. Ce type de recherche-action, impliquant gestionnaires et chercheurs, permet de valoriser des données dendrométriques en leur associant des données de biodiversité. Initié en 2008 sous l'impulsion d'Irstea, de l'ONF et de RNF, le projet "Gestion forestière, Naturalité et Biodiversité" (GNB) vise ainsi à mieux appréhender les effets de l’arrêt de l’exploitation forestière sur la biodiversité de 7 groupes taxonomiques (plantes vasculaires, bryophytes, champignons lignicoles, oiseaux, chauve-souris, carabes et coléoptères saproxyliques) en comparant des forêts couramment exploitées et des réserves où l'exploitation a été stoppée depuis au moins 20 ans. A ce jour, 213 placettes ont été échantillonnées sur 15 massifs (gnb.irstea.fr). Restreint aux habitats de hêtraies-chênaies en plaine et de hêtraies-sapinières de montagne, les résultats préliminaires du projet GNB montrent les mêmes tendances pour le bois mort. En effet, les volumes de bois mort sont les caractéristiques qui diffèrent le plus entre zones exploitées et non exploitées, avec en moyenne 4,5 fois plus de bois mort en zone non exploitée. En termes de biodiversité, les premiers résultats montrent que la mise en réserve a une influence différente en fonction du taxon étudié. Un approfondissement des analyses devrait mettre en évidence les meilleurs facteurs structurant la biodiversité forestière.
- Published
- 2013
18. The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide
- Author
-
Versporten, A, Sharland, M, Bielicki, J, Drapier, N, Vankerckhoven, V, Goossens, H, ARPEC Project Group Members, Cooper, C, Lee, Ly, Whitehouse, J, Bryant, Pa, Haeusler, G, Curtis, N, Starr, M, Vergison, A, Léon, V, Delestrait, M, Huza, C, Lepage, P, Mahieu, L, Boiy, T, Jansens, H, Van der Linden, D, Briquet, C, Allegaert, K, Smits, A, Lutsar, I, Tamm, E, Larionova, A, Orbach, D, Lorrot, M, Angoulvant, F, Doit, C, Prot-Labarthe, S, Dubos, F, Lagree, M, Biscardi, S, Decobert, F, Hau, I, Madhi, F, Durrmeyer, X, Bojang, K, Abubakr, I, Okomo, U, Awe, R, Anderson, S, Akwara, I, Ideh, Rc, Pagava, K, Hufnagel, M, Schuster, K, Henneke, P, Enimil, A, Osei-Akoto, A, Nguah, Sb, Ansong, D, Iosifidis, E, Roilides, E, Spyridis, N, Syridou, G, Soltani, J, Soleimani, N, Nahedi, S, Khosravi, F, Pouladfar, G, Jafarpour, Z, Giacquinto, C, Longo, G, Donà, D, Mion, T, D'Argenio, P, Ciofi Degli Atti ML, De Luca, M, Ciliento, G, Esposito, S, Danieli, E, Montinaro, V, Tenconi, R, Centenari, C, Nicolini, G, Mozgis, D, Sviestina, I, Pavare, J, Rasnaca, K, Gardovska, D, Grope, I, Usonis, V, Gurksniene, V, Eidukaite, A, Biver, A, Bennett, A, O'Hare, B, Kennedy, N, Brett, A, Rodrigues, F, Esteves, I, Cambrea, Sc, Craiu, M, Tomescu, E, Al Shehri MA, Al Shahrani, D, Cizman, M, Babnik, J, Kenda, R, Vidmar, I, Finlayson, H, Rabie, H, Cotton, M, Dramowski, A, Rodrigo, C, Mendez, M, Rojo, P, López-Varela, E, Ureta, N, Mosqueda, R, Pérez-López, A, Orta, L, Santos, M, Navarro, M, Santiago, B, Hernández-Sampelayo, T, Saavedra, J, Bustinza, A, Gil, J, Valls, A, Santesteban, E, Baumann, P, Berger, C, Gifford, A, Menson, E, Botgros, A, Arenas-Lopez, S, Wade, P, Doerholt, K, Drysdale, Sb, Mcelnay, Jc, Kearney, Mp, Scott, Mg, Magee, Fa, Aldeyab, M, Heginbothom, M, Newland, Jg, Hedican, Eb, Shah, H, Stach, L, and Yu, D
- Subjects
Microbiology (medical) ,Pediatrics ,medicine.medical_specialty ,medicine.drug_class ,Antibiotics ,MEDLINE ,Drug resistance ,Drug Prescriptions ,point prevalence survey ,antibiotic use ,Antibiotic resistance ,Intensive care ,Drug Resistance, Bacterial ,Medicine ,Humans ,Child ,Electronic Data Processing ,Internet ,business.industry ,Health services research ,Antimicrobial ,antimicrobial use ,Confidence interval ,Drug Utilization ,Hospitals ,Anti-Bacterial Agents ,Europe ,Infectious Diseases ,Pediatrics, Perinatology and Child Health ,surveillance ,hospitalized children ,Health Services Research ,business ,Public Health Administration - Abstract
Background The neonatal and pediatric antimicrobial point prevalence survey (PPS) of the Antibiotic Resistance and Prescribing in European Children project (http://www.arpecproject.eu/) aims to standardize a method for surveillance of antimicrobial use in children and neonates admitted to the hospital within Europe. This article describes the audit criteria used and reports overall country-specific proportions of antimicrobial use. An analytical review presents methodologies on antimicrobial use. Methods A 1-day PPS on antimicrobial use in hospitalized children was organized in September 2011, using a previously validated and standardized method. The survey included all inpatient pediatric and neonatal beds and identified all children receiving an antimicrobial treatment on the day of survey. Mandatory data were age, gender, (birth) weight, underlying diagnosis, antimicrobial agent, dose and indication for treatment. Data were entered through a web-based system for data-entry and reporting, based on the WebPPS program developed for the European Surveillance of Antimicrobial Consumption project. Results There were 2760 and 1565 pediatric versus 1154 and 589 neonatal inpatients reported among 50 European (n = 14 countries) and 23 non-European hospitals (n = 9 countries), respectively. Overall, antibiotic pediatric and neonatal use was significantly higher in non-European (43.8%; 95% confidence interval [CI]: 41.3-46.3% and 39.4%; 95% CI: 35.5-43.4%) compared with that in European hospitals (35.4; 95% CI: 33.6-37.2% and 21.8%; 95% CI: 19.4-24.2%). Proportions of antibiotic use were highest in hematology/oncology wards (61.3%; 95% CI: 56.2-66.4%) and pediatric intensive care units (55.8%; 95% CI: 50.3-61.3%). Conclusions An Antibiotic Resistance and Prescribing in European Children standardized web-based method for a 1-day PPS was successfully developed and conducted in 73 hospitals worldwide. It offers a simple, feasible and sustainable way of data collection that can be used globally.
- Published
- 2013
19. First large-scale assessment of the amount of deadwood in French forest reserves
- Author
-
Debaive, N., Drapier, N., Duchamp, L., Paillet, Yoan, Gosselin, Frédéric, Bruciamacchie, M., Gilg, Olivier, RESERVES NATURELLES DE FRANCE QUETIGNY FRA, Partenaires IRSTEA, Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)-Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA), Office National des Forêts (ONF), SYCOPARC LA PETITE PIERRE FRA, Ecosystèmes forestiers (UR EFNO), Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA), AgroParisTech, and Irstea Publications, Migration
- Subjects
[SDE] Environmental Sciences ,RESERVE FORESTIERE ,SUIVI ,[SDE]Environmental Sciences ,FRANCE - Abstract
International audience; Deadwood, whether expressed in volume, diversity or continuity, is nowadays widely acknowledged as being an important component of forest ecosystems, and has therefore been addressed in most recent studies dealing with forest conservation and management. However, and despite the growing use of the concept of naturalness in the management plans of French forest reserves, the dynamics of deadwood remains greatly unknown in West European temperate forests. In this context, and in order to answer a growing demand arising from the managers of forest reserves, a specific long-term monitoring scheme has been implemented in all main forest habitats since its launch in 2005. Our talk will present some preliminary results of this country-wide monitoring based on data from 36 Biological Reserves and 18 National Nature Reserves. In this network, a comprehensive data set of living and dead tree measurements has already been collected on >5.000 permanent plots covering a wide range of situations. Although most of the sites showed significant amounts of deadwood (mean: 38.1 m3/ha), we will focus our presentation on the important differences that were found between sites and within sites. We analyze the relationships between these differences and habitat types, altitude and management practices. Future surveys will allow us to better understand the driving forces behind these differences and will provide us with management tools to assess how these values will/can increase in the future.
- Published
- 2012
20. First large-scale assessment of the amount of DWD in strict French forest reserves
- Author
-
Debaive, N., Gilg, Olivier, Duchamp, L, Drapier, N., Paillet, Yoan, Gosselin, Frédéric, Bruciamacchie, M., RESERVES NATURELLES DE FRANCE QUETIGNY FRA, Partenaires IRSTEA, Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)-Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA), SYCOPARC LA PETITE PIERRE FRA, Office National des Forêts (ONF), Écosystèmes forestiers (UR EFNO), Centre national du machinisme agricole, du génie rural, des eaux et forêts (CEMAGREF), AgroParisTech, and Irstea Publications, Migration
- Subjects
[SDE] Environmental Sciences ,FRENCH FOREST RESERVES ,[SDE]Environmental Sciences ,FRANCE ,LONG TERM MONITORING PROTOCOL ,DEADWOOD DYNAMICS - Abstract
International audience; Deadwood, whether expressed in volume, diversity or continuity, is nowadays widely acknowledged as being an important component of forest ecosystems and has therefore been addressed in most recent studies dealing with forest conservation and management. However, and despite the growing use of the concept of naturalness in the management plans of French forest reserves, deadwood dynamics remain greatly unknown in European temperate forests. In this context and to answer a growing demand arising from reserve managers, a long-term monitoring scheme has been launched in 2005. Preliminary results from 42 French forest reserves will be presented in this talk. A comprehensive data set of living and dead tree measurements have so far been collected on more than 4000 permanent plots. Sampling is systematic but the density of plots is adjusted to the reserve size, habitat diversity and management practices. Overall, French forest reserves host an average of 35.1 m3/ha of deadwood. More than 2/3 of the reserves had deadwood volumes between 20 and 40 m3/ha, and were considered deadwood rich. For more than 1/3 of these reserves, the estimated volume was even greater than 40 m3/ha, indicative of forests growing under nearly natural conditions. Although most of the reserves showed a significant amount of deadwood, the gap with old-growth forests is still of great magnitude. The following surveys should allow us to better understand these differences.
- Published
- 2011
21. L'Alisier torminal (Sorbus torminalis (L.) Crantz
- Author
-
LANIER, L., Rameau, J.C., Keller, R., Drapier, N., Sevrin, E., Unité associée en sciences forestières, Ecole Nationale du Génie Rural, des Eaux et des Forêts (ENGREF)-Institut National de la Recherche Agronomique (INRA), and ProdInra, Migration
- Subjects
[SDV.SA.SF]Life Sciences [q-bio]/Agricultural sciences/Silviculture, forestry ,BIOLOGIE ,[SDV.SA.SF] Life Sciences [q-bio]/Agricultural sciences/Silviculture, forestry ,BOTANIQUE ,ECOLOGIE - Abstract
20 ref.; National audience
- Published
- 1990
22. Recherche d'éléments de sylviculture pour l'Alisier torminal
- Author
-
DRAPIER, N., primary
- Published
- 1993
- Full Text
- View/download PDF
23. Les Sorbus en France : caractères botaniques et généralités
- Author
-
DRAPIER, N., primary
- Published
- 1993
- Full Text
- View/download PDF
24. Ecologie et intérêt sylvicole de divers Sorbus en France
- Author
-
DRAPIER, N., primary
- Published
- 1993
- Full Text
- View/download PDF
25. Ecologie de l'Alisier torminal Sorbus torminalis (L.) Crantz
- Author
-
DRAPIER, N., primary
- Published
- 1993
- Full Text
- View/download PDF
26. A propos de la protection de l'Alisier de Fontainebleau et des essences forestières en général
- Author
-
DRAPIER, N., primary
- Published
- 1991
- Full Text
- View/download PDF
27. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey
- Author
-
Versporten, A, Zarb, P, Caniaux, I, Gros, Mf, Drapier, N, Miller, M, Jarlier, V, Nathwani, D, Goossens, H, Global-PPS, Network, Koraqi, A, Hoxha, I, Tafaj, S, Lacej, D, Hojman, M, Quiros, Re, Ghazaryan, L, Cairns, Ka, Cheng, A, Horne, Kc, Doukas, Ff, Gottlieb, T, Alsalman, J, Magerman, K, Marielle, Gy, Ljubovic, Ad, Coelho, Aam, Gales, Ac, Keuleyan, E, Sabuda, D, Boswell, Jl, Conly, Jm, Rojas, A, Carvajal, C, Labarca, J, Solano, A, Valverde, Cr, Villalobos-Vindas, Jm, Pristas, I, Plecko, V, Paphitou, N, Shaqiri, E, Rummukainen, Ml, Pagava, K, Korinteli, I, Brandt, T, Messler, S, Enimil, A, Iosifidis, E, Roilides, E, Sow, Ms, Sengupta, S, George, Jv, Poojary, A, Patil, P, Soltani, J, Jafarpour, Z, Ameen, H, Fitzgerald, D, Maor, Y, Chowers, M, Temkin, E, Esposito, S, Arnoldo, L, Brusaferro, S, Gu, Y, El-Hajji, Fd, Kim, Nj, Kambaralieva, B, Pavare, J, Zarakauska, L, Usonis, V, Burokiene, S, Ivaskeviciene, I, Mijovic, G, Duborija-Kovacevic, N, Bondesio, K, Iregbu, K, Oduyebo, O, Raka, D, Raka, L, Rachina, S, Enani, Ma, Al Shehri, M, Carevic, B, Dragovac, G, Obradovic, D, Stojadinovic, A, Radulovic, L, Wu, Je, Wei Teng Chung, G, Chen, Hh, Tambyah, Pa, Lye, D, Tan, Sh, Ng, Tm, Tay, Hl, Ling, Ml, Chlebicki, Mp, Kwa, Al, Lee, W, Beović, B, Dramowski, A, Finlayson, H, Taljaard, J, Ojeda-Burgos, G, Retamar, P, Lucas, J, Pot, W, Verduin, C, Kluytmans, J, Scott, M, Aldeyab, Ma, Mccullagh, B, Gormley, C, Sharpe, D, Gilchrist, M, Whitney, L, Laundy, M, Lockwood, D, Drysdale, Sb, Boudreaux, J, Septimus, Ej, Greer, N, Gawrys, G, Rios, E, May, S., Centre d'Immunologie et de Maladies Infectieuses ( CIMI ), Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Centre National de Référence des Mycobactéries et de la Résistance aux Antituberculeux [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP)-Laboratoire de Bactériologie-Hygiène, CHU Pitié-Salpêtrière, 47-83 bd de l'Hôpital 75651 Paris cedex 13-CHU Pitié-Salpêtrière [APHP], BioMérieux, Global-PPS network, Centre d'Immunologie et de Maladies Infectieuses (CIMI), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pierre et Marie Curie - Paris 6 (UPMC), CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), and Global-PpS Network
- Subjects
Adult ,Male ,0301 basic medicine ,Point prevalence survey ,medicine.medical_specialty ,medicine.drug_class ,030106 microbiology ,Antibiotics ,Central asia ,Voluntary participation ,Global Health ,Anatomy -- Case Reports ,Therapeutics -- Case studies ,03 medical and health sciences ,Anti-Infective Agents ,Internet based ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Prevalence ,Drug utilization ,Humans ,Medicine ,Medical prescription ,Internet ,business.industry ,lcsh:Public aspects of medicine ,Medicine (all) ,Drug Resistance, Microbial ,lcsh:RA1-1270 ,[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologie ,General Medicine ,Antimicrobial ,Hospitals ,3. Good health ,Hospitalization ,Transplantation ,[ SDV.MHEP.MI ] Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Health Care Surveys ,Emergency medicine ,Anti-infective agents ,Female ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,Human medicine ,business ,Antibiotics -- Drug utilization - Abstract
Background: The Global Point Prevalence Survey (Global-PPS) established an international network of hospitals to measure antimicrobial prescribing and resistance worldwide. We aimed to assess antimicrobial prescribing and resistance in hospital inpatients. Methods: We used a standardised surveillance method to collect detailed data about antimicrobial prescribing and resistance from hospitals worldwide, which were grouped by UN region. The internet-based survey included all inpatients (adults, children, and neonates) receiving an antimicrobial who were on the ward at 0800 h on one specific day between January and September, 2015. Hospitals were classified as primary, secondary, tertiary (including infectious diseases hospitals), and paediatric hospitals. Five main ward types were defined: medical wards, surgical wards, intensive-care units, haematology oncology wards, and medical transplantation (bone marrow or solid transplants) wards. Data recorded included patient characteristics, antimicrobials received, diagnosis, therapeutic indication according to predefined lists, and markers of prescribing quality (eg, whether a stop or review date were recorded, and whether local prescribing guidelines existed and were adhered to). We report findings for adult inpatients. Findings: The Global-PPS for 2015 included adult data from 303 hospitals in 53 countries, including eight lowermiddle-income and 17 upper-middle-income countries. 86 776 inpatients were admitted to 3315 adult wards, of whom 29 891 (34·4%) received at least one antimicrobial. 41 213 antimicrobial prescriptions were issued, of which 36 792 (89·3%) were antibacterial agents for systemic use. The top three antibiotics prescribed worldwide were penicillins with β-lactamase inhibitors, third-generation cephalosporins, and fluoroquinolones. Carbapenems were most frequently prescribed in Latin America and west and central Asia. Of patients who received at least one antimicrobial, 5926 (19·8%) received a targeted antibacterial treatment for systemic use, and 1769 (5·9%) received a treatment targeting at least one multidrug-resistant organism. The frequency of health-care-associated infections was highest in Latin America (1518 [11·9%]) and east and south Asia (5363 [10·1%]). Overall, the reason for treatment was recorded in 31 694 (76·9%) of antimicrobial prescriptions, and a stop or review date in 15 778 (38·3%). Local antibiotic guidelines were missing for 7050 (19·2%) of the 36 792 antibiotic prescriptions, and guideline compliance was 77·4%. Interpretation: The Global-PPS showed that worldwide surveillance can be accomplished with voluntary participation. It provided quantifiable measures to assess and compare the quantity and quality of antibiotic prescribing and resistance in hospital patients worldwide. These data will help to improve the quality of antibiotic prescribing through education and practice changes, particularly in low-income and middle-income countries that have no tools to monitor antibiotic prescribing in hospitals., peer-reviewed
- Full Text
- View/download PDF
28. Tree inventory data from permanent plots in French forest reserves.
- Author
-
Cateau E, Debaive N, Drapier N, Chantreau F, Gilg O, Laroche F, Morin X, Demets V, Pimenta R, Thompson L, and Paillet Y
- Subjects
- France, Forestry methods, Environmental Monitoring methods, Forests, Trees physiology, Conservation of Natural Resources methods
- Abstract
We present a data set resulting from the first round of a national monitoring program of forest reserves. It contains 9538 permanent plots, distributed across 111 study sites in mainland France (including Corsica). Notably focusing on dead wood measurement, this protocol has primarily been applied in strict forest reserves and special nature reserves (sensu Bollmann & Braunisch 2013), with 68% (6494) of the plots being currently located in strict forest reserves (unmanaged) and 24.7% (2363 plots) in forests unmanaged for at least 50 years. Sites cover a large variety of ecological conditions, from lowland to subalpine forests, but with an underrepresentation of Mediterranean forests (Table 1). The protocol assesses all the stages of a tree's life cycle, from seedling to decomposed lying dead wood. On each plot, a combination of three sampling techniques was used: (1) fixed-area inventory for regeneration, standing dead trees, living trees, and coarse woody debris (CWD) with diameter over 30 cm; (2) transect lines for CWD with diameter <30 cm; and (3) fixed-angle plot method for living trees with diameter at breast height (DBH) >30 cm (using a relascopic angle of 3%). Measurements include exact tree location (azimuth, distance), species, diameter(s), tree-related microhabitats, decay stage and bark cover, and seedling cover. With ongoing climate change, the program network can also provide important information to monitor changes in forest ecosystems. It can also be used as forest management monitoring or conservation status assessment. These data are freely available for noncommercial scientific use (Creative Commons Attribution 4.0 CC BY SA 4.0) with attribution, and this paper must be cited if this material is reused., (© 2024 The Ecological Society of America.)
- Published
- 2024
- Full Text
- View/download PDF
29. Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries.
- Author
-
Pauwels I, Versporten A, Drapier N, Vlieghe E, and Goossens H
- Subjects
- Adult, Hospitals, Humans, Prevalence, World Health Organization, Anti-Bacterial Agents therapeutic use, Anti-Infective Agents
- Abstract
Objectives: The WHO Access, Watch and Reserve (AWaRe) classification has been developed to support countries and hospitals in promoting rational use of antibiotics while improving access to these essential medicines. We aimed to describe patterns of worldwide antibiotic use according to the AWaRe classification in the adult inpatient population., Methods: The Global Point Prevalence Survey on Antimicrobial Consumption and Resistance (Global-PPS) collects hospital antibiotic use data using a standardized PPS methodology. Global-PPS 2015, 2017 and 2018 data, collected by 664 hospitals in 69 countries, were categorized into AWaRe groups to calculate proportional AWaRe use, Access-to-Watch ratios and the most common indications for treatment with selected Watch antibiotics. Only prescriptions for systemic antibiotics on adult inpatient wards were analysed., Results: Regional Access use ranged from 28.4% in West and Central Asia to 57.7% in Oceania, whereas Watch use was lowest in Oceania (41.3%) and highest in West and Central Asia (66.1%). Reserve use ranged from 0.03% in sub-Saharan Africa to 4.7% in Latin America. There were large differences in AWaRe prescribing at country level. Watch antibiotics were prescribed for a range of very different indications worldwide, both for therapeutic and prophylactic use., Conclusions: We observed considerable variations in AWaRe prescribing and high use of Watch antibiotics, particularly in lower- and upper-middle-income countries, followed by high-income countries. The WHO AWaRe classification has an instrumental role to play in local and national stewardship activities to assess prescribing patterns and to inform and evaluate stewardship activities., (© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.)
- Published
- 2021
- Full Text
- View/download PDF
30. Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017.
- Author
-
Vandael E, Latour K, Goossens H, Magerman K, Drapier N, Catry B, and Versporten A
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Antimicrobial Stewardship, Belgium epidemiology, Child, Child, Preschool, Female, Health Surveys, Humans, Infant, Infant, Newborn, Male, Middle Aged, Prevalence, Risk Factors, Young Adult, Anti-Bacterial Agents therapeutic use, Cross Infection epidemiology, Drug Utilization Review methods
- Abstract
Background: The point prevalence survey of healthcare-associated infections (HAIs) and antimicrobial use organized by the European Centre for Disease Prevention and Control (ECDC-PPS) and the Global Point Prevalence Survey of antimicrobial consumption (Global-PPS) were simultaneously performed in Belgian acute care hospitals in 2017., Methods: Belgian acute care hospitals were invited to participate in either the ECDC or Global-PPS. Hospital/ward/patient-level data were collected between September-December 2017. All patients present in the wards at 8 a.m. on the day of the PPS were included. The data of the ECDC and Global-PPS on antimicrobial consumption were pooled. Detailed data on HAIs were analysed for ECDC-PPS., Results: Overall, 110 Belgian acute care hospital sites participated in the ECDC and Global-PPS (countrywide participation rate: 81.4%, 28,007 patients). Overall, a crude prevalence of patients with at least one antimicrobial of 27.1% (95% confidence interval (CI) 26.5-27.6%) was found. The most frequently reported indications were pneumonia (23.2%), urinary tract infections (15.2%) and skin and soft tissue infections (11.9%). The reason for antimicrobial use was recorded for 81.9% of the prescriptions, a stop/review date for 40.8% and compliance with local antibiotic guidelines for 76.6%. In the ECDC-PPS, the crude prevalence of patients with at least one HAI was 7.3% (95%CI 6.8-7.7%). Most frequently reported HAIs were pneumonia (21.6%) and urinary tract infections (21.3%)., Conclusions: HAI and antimicrobial use prevalence remained stable in comparison with the previous PPS (7.1% and 27.4% in 2011 and 2015, respectively). Belgian hospitals should be further stimulated to set local targets to improve antibiotic prescribing and reduce HAI., Competing Interests: Competing interestsThe authors declare that they have no competing interests., (© The Author(s). 2020.)
- Published
- 2020
- Full Text
- View/download PDF
31. High Rates of Prescribing Antimicrobials for Prophylaxis in Children and Neonates: Results From the Antibiotic Resistance and Prescribing in European Children Point Prevalence Survey.
- Author
-
Hufnagel M, Versporten A, Bielicki J, Drapier N, Sharland M, and Goossens H
- Subjects
- Anti-Bacterial Agents classification, Anti-Bacterial Agents therapeutic use, Anti-Infective Agents classification, Anti-Infective Agents standards, Antibiotic Prophylaxis standards, Child, Hospitalized, Cross-Sectional Studies, Drug Prescriptions standards, Drug Therapy, Combination, Drug Utilization, Female, Health Care Surveys, Hospitalization, Hospitals, Pediatric, Humans, Infant, Newborn, Male, Prevalence, Anti-Infective Agents therapeutic use, Antibiotic Prophylaxis statistics & numerical data, Drug Prescriptions statistics & numerical data, Drug Resistance, Microbial
- Abstract
Background: This study was conducted to assess the variation in prescription practices for systemic antimicrobial agents used for prophylaxis among pediatric patients hospitalized in 41 countries worldwide., Methods: Using the standardized Antibiotic Resistance and Prescribing in European Children Point Prevalence Survey protocol, a cross-sectional point-prevalence survey was conducted at 226 pediatric hospitals in 41 countries from October 1 to November 30, 2012., Results: Overall, 17693 pediatric patients were surveyed and 36.7% of them received antibiotics (n = 6499). Of 6818 inpatient children, 2242 (32.9%) received at least 1 antimicrobial for prophylactic use. Of 11899 prescriptions for antimicrobials, 3400 (28.6%) were provided for prophylactic use. Prophylaxis for medical diseases was the indication in 73.4% of cases (2495 of 3400), whereas 26.6% of prescriptions were for surgical diseases (905 of 3400). In approximately half the cases (48.7% [1656 of 3400]), a combination of 2 or more antimicrobials was prescribed. The use of broad-spectrum antibiotics (BSAs), which included tetracyclines, macrolides, lincosamides, and sulfonamides/trimethoprim, was high (51.8% [1761 of 3400]). Broad-spectrum antibiotic use for medical prophylaxis was more common in Asia (risk ratio [RR], 1.322; 95% confidence interval [CI], 1.202-1.653) and more restricted in Australia (RR, 0.619; 95% CI, 0.521-0.736). Prescription of BSA for surgical prophylaxis also varied according to United Nations region. Finally, a high percentage of surgical patients (79.7% [721 of 905]) received their prophylaxis for longer than 1 day., Conclusions: A high proportion of hospitalized children received prophylactic BSAs. This represents a clear target for quality improvement. Collectively speaking, it is critical to reduce total prophylactic prescribing, BSA use, and prolonged prescription., (© The Author(s) 2018. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2019
- Full Text
- View/download PDF
32. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey.
- Author
-
Versporten A, Zarb P, Caniaux I, Gros MF, Drapier N, Miller M, Jarlier V, Nathwani D, and Goossens H
- Subjects
- Adult, Female, Health Care Surveys, Hospitalization, Hospitals, Humans, Internet, Male, Prevalence, Anti-Infective Agents therapeutic use, Drug Resistance, Microbial, Global Health statistics & numerical data
- Abstract
Background: The Global Point Prevalence Survey (Global-PPS) established an international network of hospitals to measure antimicrobial prescribing and resistance worldwide. We aimed to assess antimicrobial prescribing and resistance in hospital inpatients., Methods: We used a standardised surveillance method to collect detailed data about antimicrobial prescribing and resistance from hospitals worldwide, which were grouped by UN region. The internet-based survey included all inpatients (adults, children, and neonates) receiving an antimicrobial who were on the ward at 0800 h on one specific day between January and September, 2015. Hospitals were classified as primary, secondary, tertiary (including infectious diseases hospitals), and paediatric hospitals. Five main ward types were defined: medical wards, surgical wards, intensive-care units, haematology oncology wards, and medical transplantation (bone marrow or solid transplants) wards. Data recorded included patient characteristics, antimicrobials received, diagnosis, therapeutic indication according to predefined lists, and markers of prescribing quality (eg, whether a stop or review date were recorded, and whether local prescribing guidelines existed and were adhered to). We report findings for adult inpatients., Findings: The Global-PPS for 2015 included adult data from 303 hospitals in 53 countries, including eight lower-middle-income and 17 upper-middle-income countries. 86 776 inpatients were admitted to 3315 adult wards, of whom 29 891 (34·4%) received at least one antimicrobial. 41 213 antimicrobial prescriptions were issued, of which 36 792 (89·3%) were antibacterial agents for systemic use. The top three antibiotics prescribed worldwide were penicillins with β-lactamase inhibitors, third-generation cephalosporins, and fluoroquinolones. Carbapenems were most frequently prescribed in Latin America and west and central Asia. Of patients who received at least one antimicrobial, 5926 (19·8%) received a targeted antibacterial treatment for systemic use, and 1769 (5·9%) received a treatment targeting at least one multidrug-resistant organism. The frequency of health-care-associated infections was highest in Latin America (1518 [11·9%]) and east and south Asia (5363 [10·1%]). Overall, the reason for treatment was recorded in 31 694 (76·9%) of antimicrobial prescriptions, and a stop or review date in 15 778 (38·3%). Local antibiotic guidelines were missing for 7050 (19·2%) of the 36 792 antibiotic prescriptions, and guideline compliance was 77·4%., Interpretation: The Global-PPS showed that worldwide surveillance can be accomplished with voluntary participation. It provided quantifiable measures to assess and compare the quantity and quality of antibiotic prescribing and resistance in hospital patients worldwide. These data will help to improve the quality of antibiotic prescribing through education and practice changes, particularly in low-income and middle-income countries that have no tools to monitor antibiotic prescribing in hospitals., Funding: bioMérieux., (Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC-BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
33. An Integrative Eco-Epidemiological Analysis of West Nile Virus Transmission.
- Author
-
Tran A, L'Ambert G, Balança G, Pradier S, Grosbois V, Balenghien T, Baldet T, Lecollinet S, Leblond A, and Gaidet-Drapier N
- Subjects
- Animals, France epidemiology, Humans, Seroepidemiologic Studies, West Nile Fever epidemiology, West Nile virus isolation & purification, Zoonoses epidemiology, Animals, Wild virology, Birds virology, Culex virology, Disease Outbreaks statistics & numerical data, Horses virology, West Nile Fever transmission, Zoonoses transmission
- Abstract
West Nile disease, caused by the West Nile virus (WNV), is a mosquito-borne zoonotic disease affecting humans and horses that involves wild birds as amplifying hosts. The mechanisms of WNV transmission remain unclear in Europe where the occurrence of outbreaks has dramatically increased in recent years. We used a dataset on the competence, distribution, abundance, diversity and dispersal of wild bird hosts and mosquito vectors to test alternative hypotheses concerning the transmission of WNV in Southern France. We modelled the successive processes of introduction, amplification, dispersal and spillover of WNV to incidental hosts based on host-vector contact rates on various land cover types and over four seasons. We evaluated the relative importance of the mechanisms tested using two independent serological datasets of WNV antibodies collected in wild birds and horses. We found that the same transmission processes (seasonal virus introduction by migratory birds, Culex modestus mosquitoes as amplifying vectors, heterogeneity in avian host competence, absence of 'dilution effect') best explain the spatial variations in WNV seroprevalence in the two serological datasets. Our results provide new insights on the pathways of WNV introduction, amplification and spillover and the contribution of bird and mosquito species to WNV transmission in Southern France.
- Published
- 2017
- Full Text
- View/download PDF
34. The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children.
- Author
-
Versporten A, Bielicki J, Drapier N, Sharland M, and Goossens H
- Subjects
- Child, Child, Preschool, Cross-Sectional Studies, Drug Prescriptions standards, Drug Utilization standards, Europe, Female, Global Health, Hospitals, Humans, Infant, Male, Prevalence, Quality Indicators, Health Care, Anti-Bacterial Agents therapeutic use, Drug Prescriptions statistics & numerical data, Drug Resistance, Microbial, Drug Utilization statistics & numerical data, Health Care Surveys
- Abstract
Objectives: Previously, web-based tools for cross-sectional antimicrobial point prevalence surveys (PPSs) have been used in adults to develop indicators of quality improvement. We aimed to determine the feasibility of developing similar quality indicators of improved antimicrobial prescribing focusing specifically on hospitalized neonates and children worldwide., Methods: A standardized antimicrobial PPS method was employed. Included were all inpatient children and neonates receiving an antimicrobial at 8:00 am on the day of the PPS. Denominators included the total number of inpatients. A web-based application was used for data entry, validation and reporting. We analysed 2012 data from 226 hospitals (H) in 41 countries (C) from Europe (174H; 24C), Africa (6H; 4C), Asia (25H; 8C), Australia (6H), Latin America (11H; 3C) and North America (4H)., Results: Of 17,693 admissions, 6499 (36.7%) inpatients received at least one antimicrobial, but this varied considerably between wards and regions. Potential indicators included very high broad-spectrum antibiotic prescribing in children of mainly ceftriaxone (ranked first in Eastern Europe, 31.3%; Asia, 13.0%; Southern Europe, 9.8%), cefepime (ranked third in North America, 7.8%) and meropenem (ranked first in Latin America, 13.1%). The survey identified worryingly high use of critically important antibiotics for hospital-acquired infections in neonates (34.9%; range from 14.2% in Africa to 68.0% in Latin America) compared with children (28.3%; range from 14.5% in Africa to 48.9% in Latin America). Parenteral administration was very common among children in Asia (88%), Latin America (81%) and Europe (67%). Documentation of the reasons for antibiotic prescribing was lowest in Latin America (52%). Prolonged surgical prophylaxis rates ranged from 78% (Europe) to 84% (Latin America)., Conclusions: Simple web-based PPS tools provide a feasible method to identify areas for improvement of antibiotic use, to set benchmarks and to monitor future interventions in hospitalized neonates and children. To our knowledge, this study has derived the first global quality indicators for antibiotic use in hospitalized neonates and children., (© The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2016
- Full Text
- View/download PDF
35. The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide.
- Author
-
Versporten A, Sharland M, Bielicki J, Drapier N, Vankerckhoven V, and Goossens H
- Subjects
- Child, Drug Resistance, Bacterial, Electronic Data Processing, Europe, Hospitals, Humans, Internet, Anti-Bacterial Agents therapeutic use, Drug Prescriptions statistics & numerical data, Drug Utilization statistics & numerical data, Health Services Research methods, Health Services Research standards, Public Health Administration methods, Public Health Administration standards
- Abstract
Background: The neonatal and pediatric antimicrobial point prevalence survey (PPS) of the Antibiotic Resistance and Prescribing in European Children project (http://www.arpecproject.eu/) aims to standardize a method for surveillance of antimicrobial use in children and neonates admitted to the hospital within Europe. This article describes the audit criteria used and reports overall country-specific proportions of antimicrobial use. An analytical review presents methodologies on antimicrobial use., Methods: A 1-day PPS on antimicrobial use in hospitalized children was organized in September 2011, using a previously validated and standardized method. The survey included all inpatient pediatric and neonatal beds and identified all children receiving an antimicrobial treatment on the day of survey. Mandatory data were age, gender, (birth) weight, underlying diagnosis, antimicrobial agent, dose and indication for treatment. Data were entered through a web-based system for data-entry and reporting, based on the WebPPS program developed for the European Surveillance of Antimicrobial Consumption project., Results: There were 2760 and 1565 pediatric versus 1154 and 589 neonatal inpatients reported among 50 European (n = 14 countries) and 23 non-European hospitals (n = 9 countries), respectively. Overall, antibiotic pediatric and neonatal use was significantly higher in non-European (43.8%; 95% confidence interval [CI]: 41.3-46.3% and 39.4%; 95% CI: 35.5-43.4%) compared with that in European hospitals (35.4; 95% CI: 33.6-37.2% and 21.8%; 95% CI: 19.4-24.2%). Proportions of antibiotic use were highest in hematology/oncology wards (61.3%; 95% CI: 56.2-66.4%) and pediatric intensive care units (55.8%; 95% CI: 50.3-61.3%)., Conclusions: An Antibiotic Resistance and Prescribing in European Children standardized web-based method for a 1-day PPS was successfully developed and conducted in 73 hospitals worldwide. It offers a simple, feasible and sustainable way of data collection that can be used globally.
- Published
- 2013
- Full Text
- View/download PDF
36. Antimicrobial prescribing in hospitalized adults stratified by age: data from the ESAC point-prevalence surveys.
- Author
-
Zarb P, Amadeo B, Muller A, Drapier N, Vankerckhoven V, Davey P, and Goossens H
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Europe, Female, Humans, Male, Middle Aged, Prevalence, Quality of Health Care, Young Adult, Anti-Infective Agents therapeutic use, Data Collection, Drug Prescriptions statistics & numerical data, Hospitalization statistics & numerical data
- Abstract
Background: Geriatric infectious diseases are a major health care issue. Infections in the elderly occur more frequently than in younger adults, are often associated with higher morbidity and mortality, and may present atypically. Elderly patients are also often taking multiple medications, which increases the likelihood of drug-drug interactions. Dosing decisions should take into consideration the reduced lean body mass and declining renal function in this age group., Objective: Antimicrobial prescribing in three age groups (65-74, 75-84 and ≥85 years) was compared with a reference age group (18-64 years), with the aim of identifying quality of care indicators specific to the elderly., Methodology: The ESAC (European Surveillance of Antimicrobial Consumption) final phase performed two hospital point-prevalence surveys in 2008 and 2009, respectively, using the defined daily dose (DDD) and Anatomical Therapeutic Chemical (ATC) classification system. The prescribed daily dose (PDD) was compared with the DDD. Differences in prescribing were assessed using multivariate logistic regression analyses., Results: The majority of patients (19,549 [64% of 30,836]) were from Northern Europe and 13,830 (48%) belonged to the reference group. The largest proportion of patients was admitted through the hospital's medical specialty (55% of patients) [range: 49% in the reference group to 72% in the ≥85 years age group]. Penicillins were the most frequently used antimicrobials in all age groups (range: 32% in the reference group to 41% in the ≥85 years age group). Multivariate analyses showed three significant variations between the 65-74 years age group and the reference group (quinolones: odds ratio [OR] 1.17 [95% CI 1.05, 1.29]; tetracyclines: OR 1.58 [95% CI 1.26, 1.98]; aminoglycosides: OR 0.81 [95% CI 0.70, 0.93]). The number of significant variations increased to seven and eight in the 75-84 and ≥85 years age groups, respectively. A lower likelihood for PDD > DDD was observed in the 65-74 years age group for three parenteral antimicrobials (amoxicillin/clavulanic acid, gentamicin and vancomycin). This was reiterated in the older age groups (75-84 and ≥85 years), where piperacillin/tazobactam, meropenem and oral ciprofloxacin also showed a lower likelihood for PDD > DDD., Conclusions: Despite the methodology not being dedicated to elderly patients, the study identified elevated use of antimicrobial agents that are associated with serious adverse effects or a narrow therapeutic index as a target for quality of care improvement in elderly patients.
- Published
- 2012
- Full Text
- View/download PDF
37. Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009.
- Author
-
Zarb P, Amadeo B, Muller A, Drapier N, Vankerckhoven V, Davey P, and Goossens H
- Subjects
- Data Collection, Electronic Prescribing, Europe, Guideline Adherence trends, Hospitals statistics & numerical data, Humans, Internet, Quality of Health Care statistics & numerical data, Anti-Bacterial Agents therapeutic use, Drug Prescriptions statistics & numerical data, Drug Utilization statistics & numerical data, Drug Utilization trends, Practice Patterns, Physicians' trends
- Abstract
Objectives: Since electronic prescribing is limited to few hospitals, point prevalence surveys, such as the standardized European Surveillance of Antimicrobial Consumption point prevalence survey (ESAC PPS), are an alternative tool for monitoring prescribing and helping to identify performance indicators and prescribing trends. The main objective of this study was to identify and assess targets for quality improvement., Methods: Each hospital had to carry out the survey within 2 weeks. Each department had to be surveyed in 1 day. Data collected, for all inpatients, included age and gender. For patients on systemic antimicrobial treatment, the antimicrobial/s, infection/prophylaxis site, reason in medical notes and guideline compliance were also collected. A central database using a web-based tool (WebPPS) developed in-house was used for data entry., Results: Combination of two or more antimicrobials accounted for 30% of use. Surgical prophylaxis was prolonged (>1 day) in 53% of cases. 'Intensive care' had higher proportions of treated patients (53% versus 29%), combination therapy (49% versus 31%), hospital-acquired infections (49% versus 31%) and parenteral administration (91% versus 61%). 'Reason in notes' was documented in 76%, and 'guideline compliance' occurred in 62% of patients., Conclusions: The ESAC PPS provided useful information on the quality of prescribing, which identified a number of targets for quality improvement. These could apply to specific departments or whole hospitals. Intensive care, which has different characteristics, should not be compared with general wards with respect to combination therapy, hospital-acquired infections or parenteral proportion. The study confirmed that the ESAC PPS methodology can be used on a large number of hospitals at regional, national, continental or global level.
- Published
- 2011
- Full Text
- View/download PDF
38. European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 European countries.
- Author
-
Amadeo B, Zarb P, Muller A, Drapier N, Vankerckhoven V, Rogues AM, Davey P, and Goossens H
- Subjects
- Adolescent, Antibiotic Prophylaxis methods, Antibiotic Prophylaxis statistics & numerical data, Child, Child, Preschool, Drug Prescriptions standards, Drug Therapy, Combination methods, Drug Therapy, Combination statistics & numerical data, Drug Utilization standards, Europe, Female, Hospitals, Humans, Infant, Infant, Newborn, Infusions, Parenteral statistics & numerical data, Male, Anti-Bacterial Agents administration & dosage, Drug Prescriptions statistics & numerical data, Drug Utilization statistics & numerical data
- Abstract
Background: Antimicrobials are the most common medicines prescribed to children, but very little is known about patterns of hospital paediatric antimicrobial prescribing. This study aimed at describing paediatric antimicrobial prescribing in European hospitals to identify targets for quality improvement., Methods: The European Surveillance of Antibiotic Consumption (ESAC) project (www.esac.ua.ac.be) collected data during 2 calendar weeks between May and June 2008 in 32 hospitals of 21 European countries with paediatric departments, using a standardized method. The ESAC point prevalence survey included all inpatient beds and identified all patients who were receiving systemic antimicrobials on the day of the survey or had received antimicrobial surgical prophylaxis on the previous day., Results: Of 1799 children, 583 (32%) received one or more antimicrobials (range 17%-100%). The indications were therapeutic in 71%, prophylactic in 26% and both indications in 3% of patients. The parenteral route was used in 82% of therapeutic indications and in 63% of prophylactic indications. Third-generation cephalosporins were the most prescribed antimicrobials for therapeutic indications (18%). A high proportion of treated children received antimicrobial combinations (37%). The most commonly treated diagnosis site was the respiratory tract for both therapeutic use (30%) and prophylaxis (25%). The duration of surgical prophylaxis was >1 day in 67%., Conclusions: Targets identified for quality improvement of antimicrobial use in children included excessive use of antimicrobial combinations and a high proportion of parenteral antimicrobials, both of which require further investigation. Surgical prophylaxis for >1 day should also be curbed in order to achieve quality improvement.
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.